Arcus Biosciences, Inc. (RCUS)
25.06
-1.33
(-5.04%)
USD |
NYSE |
Sep 24, 16:00
25.85
+0.79
(+3.15%)
Pre-Market: 07:11
Arcus Biosciences Gross Profit (Annual) : 237.00M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 237.00M |
| December 31, 2024 | 248.00M |
| December 31, 2023 | 101.00M |
| December 31, 2022 | 98.00M |
| December 31, 2021 | 375.82M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | -1.199M |
| December 31, 2016 | -1.314M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 1.091B |
| AVITA Medical, Inc. | 58.82M |
| Iovance Biotherapeutics, Inc. | 54.38M |
| Editas Medicine, Inc. | 35.24M |
| Recursion Pharmaceuticals, Inc. | -46.27M |